
Scan how Hercules Capital’s latest 6.700% bond issue compares with other lenders reshaping their funding mix by reviewing our hand picked list of solid balance sheet and fundamentals (25 results) for potential ideas.
To own Hercules Capital, you need to be comfortable with a lender that is tightly linked to venture backed technology and life sciences, and that relies on leverage to grow. The short term story still pivots on sustaining record level originations and fundings while keeping credit performance steady in those concentrated sectors.
The biggest near term swing factor remains portfolio quality and how competition in venture lending affects pricing and covenants. The main risk is that higher fixed interest costs and already elevated leverage compress net margins, especially if repayments, prepayment fees or new deployments slow. This new bond does not radically change that equation.
The new 6.700% senior unsecured notes due 2029 sit alongside Hercules Capital’s existing 2029 and 2031 unsecured issues. Together, these bonds indicate that the business is relying heavily on wholesale funding rather than lower risk deposits, which matters for anyone focused on interest coverage and debt servicing capacity.
Access to this scale of long term debt can support the funding of technology and life sciences loans without relying as heavily on new equity, which many shareholders will watch closely. The trade off is higher fixed interest obligations added to a balance sheet where debt is already not well covered by operating cash flow, so execution on credit discipline and originations remains central.
Hercules Capital’s analyst narrative points to revenues of US$700.2 million and earnings of US$399.0 million by 2029, based on forecasts that imply 7.3% yearly revenue growth and an earnings increase of about US$18.7 million from current earnings of US$380.3 million.
Discover how Hercules Capital's fair value indicates a 17% potential upside to its current price, which could close faster than many investors expect.
One alternate view on Hercules Capital focuses less on competition risk and more on the potential upside from adviser fee income. The most optimistic analysts were penciling in about US$728.3 million of revenue and US$433.2 million of earnings by 2029. Those figures come from before this new 6.700% bond, so you should expect opinions to evolve as fresh funding data filters through.
Explore 3 other Hercules Capital fair value estimates, including one that suggests there could be as much as 53% upside from the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Once you have formed a view on Hercules Capital, it can help to line that thesis up against other opportunities that fit different risk and income preferences using the Simply Wall St Screener.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com